Dillon Michael P.'s Form 4 filing
IDEAYA Biosciences, Inc. (IDYA) · filed Jul 29, 2021
- Accession no.
- 0001567619-21-014178
- Filed
- Jul 29, 2021
- Trade date
- Jul 27, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $251.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dillon Michael P.CIK 0001777415 | Officer (SVP, Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | MOption exerciseAcquired | +5,000 | $6.92 | +$34,600 | 103,789 | Direct | |
| Jul 27, 2021 | Common Stock | MOption exerciseAcquired | +5,000 | $4.31 | +$21,550 | 108,789 | Direct | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −10,000 | $25.15 | −$251,500 | 98,789 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 39,500 | Direct | |
| Jul 27, 2021 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 67,735 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.